Skip to content

A Long-term Follow-up Study of Patients Who Received VOR33

Leukemia, Myeloid, Acute

VOR33 long-term follow-up (LTFU) study

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    0 and up

Participation Criteria

Inclusion Criteria:

* A patient is included in this study if he/she:

1. Has received any part of or all of a VOR33 infusion

Exclusion Criteria:

* There are no exclusion criteria.

Study Location

Hôpital Maisonneuve-Rosemont
Hôpital Maisonneuve-Rosemont
Montréal, Quebec
Canada

Contact Study Team

Primary Contact

Lea Bernard, MD

[email protected]
514-252-3404
Study Sponsored By
Vor Biopharma
Participants Required
More Information
Study ID: NCT05309733